THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WITH RENAL DISEASE

被引：0
|
作者：
Jayne, David [1 ]
Merkel, Peter [2 ]
Bekker, Pirow [3 ]
McMahon, Jeffrey [3 ]
Schall, Thomas J. [3 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Hosp Univ Penn, Div Rheumatol, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] ChemoCentryx Inc, Mountain View, CA USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FC032
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Effect on Renal Function of the Complement C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
    Merkel, Peter
    Bekker, Pirow
    Yue, Huibin
    Kelleher, Catherine
    Schall, Thomas
    Jayne, David
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David
    Merkel, Peter
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    Bekker, Pirow
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4117 - 4120
  • [3] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David R.
    Merkel, Peter A.
    Bekker, Pirow
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B1 - B1
  • [4] Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Bruchfeld, Annette N.
    Harper, Lorraine
    Schaier, Matthias
    Venning, Michael C.
    Hamilton, Patrick
    Burst, Volker
    Grundmann, Franziska
    Jadoul, Michel
    Szombati, Istvan
    Tesar, Vladimir
    Segelmark, Marten
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (09): : 2756 - 2767
  • [5] The Effect of Treatment with the Complement C5a Receptor Inhibitor Avacopan on Health-Related Quality of Life in ANCA-Associated Vasculitis
    Strand, Vibeke
    Bekker, Pirow
    Yue, Huibin
    Jayne, David R. W.
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1990 - 1992
  • [6] C5A AND ITS RECEPTOR IN ANCA-ASSOCIATED VASCULITIS
    Zhao, M. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 32 - 33
  • [7] Avacopan for Patients with ANCA-associated Vasculitis
    Rauen, Thomas
    Kraemer, Stefan
    Floege, Juergen
    NEPHROLOGIE, 2022, 17 (02): : 117 - 118
  • [8] Fatigue in patients with ANCA-associated vasculitis: is avacopan the answer?
    Tervaert, Jan Willem Cohen
    LANCET RHEUMATOLOGY, 2023, 5 (08): : E429 - E430
  • [9] Change in Albuminuria in Patients with ANCA-Associated Vasculitis Treated with Avacopan
    Geetha, Duvuru
    Cortazar, Frank
    Karras, Alexandre
    Bruchfeld, Annette
    Yue, Huibin
    Merkel, Peter
    Jayne, David
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1719 - 1721
  • [10] CHANGE IN ALBUMINURIA IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH AVACOPAN
    Geetha, Duvuru
    Cortazar, Frank
    Karras, Alexandre
    Bruchfeld, Annette
    Yue, Huibin
    Merkel, Peter
    Jayne, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I296 - I298
12345